GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,000 | -63.3% | 425 | -50.0% | 0.00% | – |
| Q2 2021 | $30,000 | -11.8% | 850 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | -83.2% | 850 | 0.0% | 0.00% | – |
| Q4 2020 | $202,000 | +339.1% | 850 | 0.0% | 0.00% | – |
| Q3 2020 | $46,000 | -14.8% | 850 | 0.0% | 0.00% | – |
| Q2 2020 | $54,000 | +145.5% | 850 | +100.0% | 0.00% | – |
| Q1 2020 | $22,000 | -35.3% | 425 | 0.0% | 0.00% | – |
| Q4 2019 | $34,000 | -15.0% | 425 | -48.8% | 0.00% | – |
| Q3 2019 | $40,000 | +81.8% | 830 | +95.3% | 0.00% | – |
| Q2 2019 | $22,000 | 0.0% | 425 | 0.0% | 0.00% | – |
| Q1 2019 | $22,000 | +29.4% | 425 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | +6.2% | 425 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -15.8% | 425 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | -9.5% | 425 | 0.0% | 0.00% | – |
| Q1 2018 | $21,000 | +23.5% | 425 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | – | 425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |